Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
SELLAS Life Sciences Group Inc

Start price
Target price
Perf. (%)
€2.15
15.11.22
-
15.11.23
-26.97%
24.02.23

Madrigal Pharmaceuticals inc.

Start price
Target price
Perf. (%)
€69.50
14.11.22
-
14.11.23
239.57%
21.12.22

buy
Madrigal Pharmaceuticals inc.

Start price
Target price
Perf. (%)
€69.50
14.11.22
-
14.11.23
-7.91%
26.11.22

buy
PDS Biotechnology Corp.

Start price
Target price
Perf. (%)
€6.75
14.11.22
€10.00
14.11.23
31.66%
17.11.22

Could be very worthwhile Investment >20% year
Very capable Management
Very good company culture
Few uniques
Riot Blockchain Inc.

Start price
Target price
Perf. (%)
€4.80
14.11.22
-
14.11.23
-13.88%
28.11.22

Could be worthwhile Investment >10% per year
Very high cyclical dependencies
buy
Ardelyx Inc.

Start price
Target price
Perf. (%)
€1.22
13.11.22
-
13.11.23
268.70%
02.04.23

buy
MacroGenics Inc.

Start price
Target price
Perf. (%)
€7.15
13.11.22
-
13.11.23
-20.98%
26.11.22

Could be worthwhile Investment >10% per year
buy
MorphoSys AG

Start price
Target price
Perf. (%)
€17.03
13.11.22
-
13.11.23
-14.24%
26.11.22

Ardelyx Inc.

Start price
Target price
Perf. (%)
€1.22
13.11.22
-
13.11.23
42.39%
26.11.22

buy
Immunic Inc.

Start price
Target price
Perf. (%)
€1.41
12.11.22
-
12.11.23
-5.42%
26.11.22

buy
Jounce Therapeutics Inc

Start price
Target price
Perf. (%)
€0.96
12.11.22
-
12.11.23
-21.08%
26.11.22

buy
Evotec SE

Start price
Target price
Perf. (%)
€19.00
12.11.22
€25.00
12.11.23
-7.37%
12.11.23

Could be worthwhile Investment >10% per year
Standard Investments for future growth
Innovative
Some uniques
buy
MyMD Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€2.12
12.11.22
€280.00
12.11.23
-87.36%
13.11.23

Oncopeptides AB

Start price
Target price
Perf. (%)
€1.96
12.11.22
€0.000
12.11.23
-17.89%
26.11.22

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
buy
MorphoSys AG

Start price
Target price
Perf. (%)
€21.07
11.11.22
-
11.12.22
-22.19%
12.12.22

buy
Bayer AG

Start price
Target price
Perf. (%)
€50.56
11.11.22
-
11.12.22
4.45%
12.12.22

buy
AstraZeneca plc

Start price
Target price
Perf. (%)
€124.30
11.11.22
€165.00
08.09.26
19.18%
13.09.24

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
positive Cash Flow expected
buy
Jounce Therapeutics Inc

Start price
Target price
Perf. (%)
€1.37
10.11.22
-
10.11.23
-29.49%
12.11.22

buy
WAVE Life Sciences Ltd

Start price
Target price
Perf. (%)
€4.15
10.11.22
-
10.11.23
-7.07%
19.11.22

buy
Eiger Biopharmaceuticals Inc

Start price
Target price
Perf. (%)
€4.00
10.11.22
-
10.11.23
2.53%
26.11.22

Risky Investment
buy
Apellis Pharmaceuticals

Start price
Target price
Perf. (%)
€44.20
10.11.22
-
10.11.23
49.32%
02.04.23

buy
Bayer AG

Start price
Target price
Perf. (%)
€50.37
10.11.22
€70.00
10.11.25
-41.08%
13.09.24

buy
Merck KGaA

Start price
Target price
Perf. (%)
€170.60
09.11.22
-
09.11.23
-10.11%
10.11.23

buy
Kala Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€6.61
09.11.22
-
09.11.23
-17.10%
26.11.22

buy
Riot Blockchain Inc.

Start price
Target price
Perf. (%)
€5.02
09.11.22
-
09.11.23
-16.76%
21.11.22